Today, the integration of AI and digital technologies is fundamentally rewriting the rules of R&D—serving as the ultimate breakthrough to shatter industry bottlenecks and drive unprecedented ...

Anthropic announced the creation of its new Claude Science tool, which aims to help scientists speed up the drug development ...

Scientists have identified a promising new strategy to tackle one of the biggest obstacles in treating glioblastoma, one of the most aggressive form of brain cancer: resistance to chemotherapy. The ...

The Trump administration has released its latest unified agenda, laying out the proposed and final rules its agencies plan to ...

The tailor-made comprehensive offering spans a diversified clinical and commercial portfolio of innovative modalities, ...

Through predictive modelling, AI supports target identification, prediction of physicochemical properties and formulation strategy selection.

An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial ...

Many clinically relevant molecules fall by the wayside because of the complex challenge of purifying them at industrial scale ...

The biotechnology company will use the federal pilot program for its planned $2 billion Saratoga Springs manufacturing campus ...

Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...

Anthropic also went a step further, saying it would develop drugs of its own. Head of life sciences Eric Kauderer-Abrams said ...

Healthcare veteran Dr Douglas Williams discusses the impact of recent political upheaval in the US and the prospect of major ...